http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006026611-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_04deaaad0108a94487469f16fd0b65f9 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1276 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 |
| filingDate | 2005-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c214f813fb6d0626af1d08b4733b212 |
| publicationDate | 2006-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2006026611-A2 |
| titleOfInvention | Reverse transcriptase mediated rna gene expression |
| abstract | The present invention provides methods and compositions for expressing a polypeptide or nucleic acid of interest in cells expressing reverse transcriptase (RT). The compositions of the invention include reverse transcriptase RNA (RTD-RNA) molecules that are designed to be reverse transcribed into a DNA molecule capable of encoding a polypeptide or nucleic acid of interest. Polypeptides of interest include cytotoxic, therapeutic, enzymatic, or reporter polypeptides. Nucleic acid molecules of interest include those capable of regulating, altering or reprogramming gene expression, for example, those capable of functioning as antisense, aptamer, decoy, inhibitor, ribozyme, or RNAi molecules. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10987433-B2 |
| priorityDate | 2004-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1146.